RhumbLine Advisers’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q2 | – | Sell |
-46,463
| Closed | -$2.48M | – | 3135 |
|
2016
Q1 | $2.48M | Buy |
46,463
+1,035
| +2% | +$55.3K | 0.01% | 1224 |
|
2015
Q4 | $5.13M | Buy |
45,428
+2,915
| +7% | +$329K | 0.02% | 810 |
|
2015
Q3 | $5M | Buy |
42,513
+2,621
| +7% | +$309K | 0.02% | 811 |
|
2015
Q2 | $3.09M | Sell |
39,892
-2,570
| -6% | -$199K | 0.01% | 1132 |
|
2015
Q1 | $2.46M | Buy |
42,462
+4,050
| +11% | +$234K | 0.01% | 1259 |
|
2014
Q4 | $1.24M | Buy |
38,412
+2,175
| +6% | +$70.2K | ﹤0.01% | 1669 |
|
2014
Q3 | $887K | Sell |
36,237
-700
| -2% | -$17.1K | ﹤0.01% | 1839 |
|
2014
Q2 | $655K | Buy |
36,937
+14,703
| +66% | +$261K | ﹤0.01% | 2097 |
|
2014
Q1 | $445K | Sell |
22,234
-1,200
| -5% | -$24K | ﹤0.01% | 2295 |
|
2013
Q4 | $393K | Buy |
23,434
+300
| +1% | +$5.03K | ﹤0.01% | 2403 |
|
2013
Q3 | $246K | Sell |
23,134
-241
| -1% | -$2.56K | ﹤0.01% | 2669 |
|
2013
Q2 | $131K | Buy |
+23,375
| New | +$131K | ﹤0.01% | 3176 |
|